Moderate to Severe Refractory Autoimmune Diseases Clinical Trials in Shanghai, Shanghai Municipality

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases